Dr. Richard Horowitz, Dr. Phyllis Freeman, and James Bruzzese have published their case report, “Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases” evaluating two patients with Lyme disease and COVID-19 in Respiratory Medicine Case Reports.
Below is a compilation of Covid-19 information from scientific sources compiled by Dr. Robert Bransfield, MD that the LDA has permission to post. Dr. Bransfield thanks contributors to this project: members of ILADS, Microbes and Mental Illness listserv, and Psychopharmacology listserv. Disclaimer: The LDA is providing this piece for informational purposes only. The opinions expressed […]
Robert, Bransfield, MD, is lead author on the just-published “A Clinical Diagnostic System for Late-Stage Neuropsychiatric Lyme Borreliosis Based upon an Analysis of 100 Patients” in the peer-reviewed scientific journal Healthcare. The published study identifies that many late-stage chronic Lyme disease clinical findings are neuropsychiatric and therefore a complete clinical assessment is critical in […]
The Asian longhorned tick, Haemaphysalis longicornis, first detected in New Jersey in 2017, has since been recorded from 88 counties across 12 eastern states. This highly invasive tick is able to reproduce asexually and is considered an important vector of human pathogens in it native range of Asia. Since it’s detection in the US, many […]
The Connecticut Agricultural Experiment Station (CAES) and US Biologic, Inc. released the publication of a field trial study showing the effectiveness of an orally-delivered anti-Lyme vaccine that targets the white-footed mouse, the major wildlife source of Lyme disease. The study took place in the residential area of Redding, CT, over a three-year time period and […]
A study by Elizabeth Lee-Lewandrowski, PhD, MPH, et al, published in The American Journal of Clinical Pathology from the Department of Pathology, Massachusetts General Hospital and Harvard Medical School, evaluated trends in non-Lyme disease tick-borne disease (NLTBI) blood testing at Quest Diagnostics laboratory located in New Jersey. The study took place over the course of […]
Brian A. Fallon, Barbara Strobino et al. released the results of a recent study in Brain, Behavior, & Immunity – Health. The article was published on January 7, 2020 and is titled “Anti-lysoganglioside and other anti-neuronal autoantibodies in post-treatment Lyme Disease and Erythema Migrans after repeat infection”. Excerpts from the Abstract: Background: Molecular mimicry targeting […]
Brian A. Fallon, Nevena Zubcevik et al. published an article in Frontiers in Medicine, December 6, 2019, The General Symptom Questionnaire-30 (GSQ-30): A Brief Measure of Multi-System Symptom Burden in Lyme Disease. Conclusions and Relevance of the study: “The GSQ-30 is a valid and reliable instrument to assess symptom burden among patients with acute and […]
The International Lyme and Associated Diseases Society (ILADS), a nonprofit, international, multidisciplinary medical organization, has provided an evidence-based definition of Chronic Lyme Disease (CLD) published in the journal Antibiotics as a concept paper. ILADS has defined CLD as “a multisystem illness with a wide range of symptoms and/or signs that are either continuously or intermittently […]
Researchers, including Robert C. Bransfield, MD, Lyme Disease Association Professional & Medical Advisory Board Member, recently reviewed the proposed new Lyme Disease Guidelines, a 100 page document on the prevention, diagnosis, and treatment of Lyme disease drafted by the Infectious Disease Society of America (IDSA) in collaboration with the American Academy of Neurology and American […]